Neutropenic enterocolitis associated with docetaxel therapy in a patient with breast cancer.
Rolston
Kenneth V I
KV
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas, M.D. Anderson Cancer Center, Houston, USA. krolston@mdanderson.org
D000230:Adenocarcinoma / Q000188:drug therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D000077143:Docetaxel; D044504:Enterocolitis, Neutropenic / Q000139:chemically induced* / Q000382:microbiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000150:complications; D011550:Pseudomonas aeruginosa; D043823:Taxoids / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel